Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Thalidomide/analogs & derivatives"'
Autor:
Shabnam Shaabani, Louis Gadina, Ewa Surmiak, Zefeng Wang, Bidong Zhang, Roberto Butera, Tryfon Zarganes-Tzitzikas, Ismael Rodriguez, Justyna Kocik-Krol, Katarzyna Magiera-Mularz, Lukasz Skalniak, Alexander Dömling, Tad A. Holak
Publikováno v:
Molecules; Volume 27; Issue 11; Pages: 3454
Molecules, 27(11):3454. MDPI AG
Molecules, 27(11):3454. MDPI AG
New biphenyl-based chimeric compounds containing pomalidomide were developed and evaluated for their activity to inhibit and degrade the programmed cell death-1/programmed cell death- ligand 1 (PD-1/PD-L1) complex. Most of the compounds displayed exc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cabca6e10d067e28e99cac5b676705d
https://ruj.uj.edu.pl/xmlui/handle/item/298474
https://ruj.uj.edu.pl/xmlui/handle/item/298474
Autor:
Christina Kunz, Elias K. Mai, Hartmut Goldschmidt, Axel Benner, Christof Scheid, Manola Zago, Dirk Hose, Anna Jauch, Markus Munder, Katja Weisel, Jan Duerig, Anja Seckinger, Mathias Haenel, Hans-Walter Lindemann, Hans Salwender, Britta Besemer
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 4, Pp 1-4 (2019)
Blood Cancer Journal
Blood Cancer Journal
CA extern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d80c4b2f245489bda623e21c4a8fb14
http://link.springer.com/article/10.1038/s41408-019-0206-8
http://link.springer.com/article/10.1038/s41408-019-0206-8
Autor:
Dirk Hose, Stefan Schönland, Christoph Kimmich, Ute Hegenbart, Hartmut Goldschmidt, Axel Benner, Anthony D. Ho, Anja Freiberger, Jörg Beimler, Tilmann Bochtler, Arnt V. Kristen, Markus Zorn, Anna Jauch, Ernst Hund, Marianne Gawlik, Natalia Becker
Publikováno v:
Haematologica
Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3458f87fe310cad9b9cf2b796bb45409
https://doi.org/10.3324/haematol.2016.163246
https://doi.org/10.3324/haematol.2016.163246
Publikováno v:
Clinical Reviews in Allergy and Immunology, Vol. 54, No 1 (2018) pp. 177-184
Recognition and timely adequate treatment of erythema multiforme remain a major challenge. In this review, current diagnostic guidelines, potential pitfalls, and modern/novel treatment options are summarized with the aim to help clinicians with diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::494cbe07ef08f092095c39e05bb0a4ba
https://archive-ouverte.unige.ch/unige:115272
https://archive-ouverte.unige.ch/unige:115272
Autor:
Philip L. McCarthy, Sarah A. Holstein, Maria Teresa Petrucci, Paul G. Richardson, Cyrille Hulin, Patrizia Tosi, Sara Bringhen, Pellegrino Musto, Kenneth C. Anderson, Denis Caillot, Francesca Gay, Philippe Moreau, Gerald Marit, Sin-Ho Jung, Zhinuan Yu, Benjamin Winograd, Robert D. Knight, Antonio Palumbo, Michel Attal
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (29), pp.3279-3289. ⟨10.1200/JCO.2017.72.6679⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2017, 35 (29), pp.3279-3289. ⟨10.1200/JCO.2017.72.6679⟩
Purpose Lenalidomide maintenance therapy after autologous stem-cell transplantation (ASCT) demonstrated prolonged progression-free survival (PFS) versus placebo or observation in several randomized controlled trials (RCTs) of patients with newly diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c90cd491ac014a1bbef57b2f6073ac
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01697539
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01697539
Autor:
Martin Schreder, Arnold Bolomsky, Niklas Zojer, Tobias Meißner, Heinz Ludwig, Dirk Hose, Sabine Pfeifer
Publikováno v:
Experimental Hematology. 42:516-525
Osteoblastic activity is severely impaired in active myeloma, contributing to the development of myeloma bone disease. Although several drugs reducing osteoclast-mediated bone degradation are in clinical use, approaches to specifically augment bone f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadc383af9285f518a1bbf0536cd2e44
https://doi.org/10.1016/j.exphem.2014.03.005
https://doi.org/10.1016/j.exphem.2014.03.005
Autor:
Yordanova, Anna, Hose, Dirk, Neben, Kai, Witzens-Harig, Mathias, Gütgemann, Ines, Raab, Marc-Steffen, Moehler, Thomas, Goldschmidt, Hartmut, Schmidt-Wolf, Ingo G H
Sorafenib is a small molecular inhibitor of several tyrosine protein kinases, including vascular endothelial growth factor receptor, platelet-derived growth factor receptor and rapidly accelerated fibrosarcoma kinases, targeting signal transduction a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::41e478693efdab0c737f5aef25939174
https://doi.org/10.1002/hon.2043
https://doi.org/10.1002/hon.2043
Autor:
Taverna, C., Bargetzi, M., Betticher, D., Gmur, J., Gregor, M., Heim, D., Hess, U., Ketterer, N., Lerch, E., Matthes, Thomas, Mey, U., Pabst, T., Renner, Christoph
Publikováno v:
Swiss Medical Weekly, vol. 140, pp. w13054
Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13054
Schweizerische medizinische Wochenschrift, Vol. 140 (2010) P. w13054
The treatment of multiple myeloma has undergone significant changes in the recent past. The arrival of novel agents, especially thalidomide, bortezomib and lenalidomide, has expanded treatment options and patient outcomes are improving significantly.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f630e5a07ef469b041755bd84db8ab07
https://serval.unil.ch/resource/serval:BIB_8873EB254E5F.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_8873EB254E5F.P001/REF.pdf